TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update

Go back to TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 4.55 --0 (-0%)
Previous Close $4.55    52 Week High
Open $4.55    52 Week Low
Day High $4.55    P/E N/A 
Day Low $4.55    EPS
Volume 113